How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies

• Valerio Nardone,
• Pierpaolo Pastina,
• Rocco Giannicola,
• Rita Agostino,
• Stefania Croci,
• Paolo Tini,
• Paolo Tini,
• Luigi Pirtoli,
• Antonio Giordano,
• Antonio Giordano,
• Pierosandro Tagliaferri,
• Pierosandro Tagliaferri,
• Pierpaolo Correale

Affiliations

Valerio Nardone

Radiation Oncology Unit, University Hospital of Siena, Siena, Italy

Pierpaolo Pastina

Radiation Oncology Unit, University Hospital of Siena, Siena, Italy

Rocco Giannicola

Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria, Italy

Rita Agostino

Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria, Italy

Stefania Croci

Radiation Oncology Unit, University Hospital of Siena, Siena, Italy

Paolo Tini

Radiation Oncology Unit, University Hospital of Siena, Siena, Italy

Paolo Tini

Sbarro Health Research Organization, Temple University, Philadelphia, PA, United States

Luigi Pirtoli

Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, United States

Antonio Giordano

Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, United States

Antonio Giordano

Department of Medicine, Surgery and Neurosciences University of Siena, Siena, Italy

Pierosandro Tagliaferri

Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy

Pierosandro Tagliaferri

Medical Oncology Unit, Azienda Ospedaliero – Universitaria “Mater Domini”, Catanzaro, Italy

Pierpaolo Correale

Medical Oncology Unit, Grand Metropolitan Hospital “Bianchi Melacrino Morelli”, Reggio Calabria, Italy